BOSTON SCIENTIFIC CORP

NYSE: BSX (Boston Scientific Corporation)

Kemas kini terakhir: 2 hari lalu, 7:28PM

59.52

-1.47 (-2.41%)

  • 1H -2.41%
  • 5H -6.74%
  • 1B -12.66%
  • 6B -41.13%
  • Tahun Ke Tarikh -37.16%
  • 1T -41.15%
  • 5T 40.81%
Penutupan Terdahulu 60.99
Buka 60.74
Jumlah Dagangan 26,820,967
Purata Dagangan (3B) 16,409,962
Modal Pasaran 88,457,142,272
Harga / Pendapatan (P/E TTM) 31.49
Harga / Pendapatan (P/E Ke hadapan) 18.62
Harga / Jualan (P/S) 4.78
Harga / Buku (P/B) 3.94
Julat 52 Minggu
59.39 (-0%) — 109.50 (83%)
Tarikh Pendapatan 22 Apr 2026
Margin Keuntungan 11.58%
Margin Operasi (TTM) 20.09%
EPS Cair (TTM) 1.37
Pertumbuhan Hasil Suku Tahunan (YOY) 20.90%
Pertumbuhan Pendapatan Suku Tahunan (YOY) 36.20%
Jumlah Hutang/Ekuiti (D/E MRQ) 52.16%
Nisbah Semasa (MRQ) 1.45
Aliran Tunai Operasi (OCF TTM) 3.81 B
Aliran Tunai Bebas Leveraj (LFCF TTM) 2.32 B
Pulangan Atas Aset (ROA TTM) 5.28%
Pulangan Atas Ekuiti (ROE TTM) 9.50%

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Medical Devices (US) Bercampur Menurun
Medical Devices (Global) Bercampur Menurun
Stok Boston Scientific Corporation Menurun Menurun

AISkor Stockmoo

2.5
Konsensus Penganalisis 3.0
Aktiviti Orang Dalam NA
Volatiliti Harga 5.0
Purata Bergerak Teknikal 2.5
Osilator Teknikal -0.5
Purata 2.50

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B
BSX 88 B - 31.49 3.94
SYK 126 B 1.02% 39.14 5.77
ABT 161 B 1.85% 25.97 3.34
MDT 107 B 3.13% 23.25 2.26
PHG 27 B 3.48% 26.13 2.15
EW 47 B - 45.04 4.52

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
Sektor Healthcare
Industri Medical Devices
Gaya Pelaburan Large Core
% Dimiliki oleh Orang Dalam 0.18%
% Dimiliki oleh Institusi 93.22%

Pemilikan

Nama Tarikh Syer Dipegang
Bollard Group Llc 31 Dec 2025 19,000,469
Julat 52 Minggu
59.39 (-0%) — 109.50 (83%)
Julat Harga Sasaran
94.00 (57%) — 124.00 (108%)
Tinggi 124.00 (Barclays, 108.33%) Beli
Median 105.00 (76.41%)
Rendah 94.00 (Wells Fargo, 57.93%) Beli
94.00 (Citigroup, 57.93%) Beli
Purata 106.13 (78.31%)
Jumlah 16 Beli
Harga Purata @ Panggilan 77.71
Syarikat Tarikh Harga Sasaran Panggilan Harga @ Panggilan
Citigroup 11 Mar 2026 94.00 (57.93%) Beli 69.63
05 Feb 2026 102.00 (71.37%) Beli 77.64
Canaccord Genuity 17 Feb 2026 109.00 (83.13%) Beli 76.29
05 Feb 2026 112.00 (88.17%) Beli 77.64
BTIG 09 Feb 2026 110.00 (84.81%) Beli 74.12
04 Feb 2026 110.00 (84.81%) Beli 75.50
Baird 05 Feb 2026 101.00 (69.69%) Beli 77.64
Evercore ISI Group 05 Feb 2026 96.00 (61.29%) Beli 77.64
JP Morgan 05 Feb 2026 100.00 (68.01%) Beli 77.64
Mizuho 05 Feb 2026 115.00 (93.21%) Beli 77.64
Morgan Stanley 05 Feb 2026 118.00 (98.25%) Beli 77.64
Needham 05 Feb 2026 97.00 (62.97%) Beli 77.64
RBC Capital 05 Feb 2026 115.00 (93.21%) Beli 77.64
Stifel 05 Feb 2026 110.00 (84.81%) Beli 77.64
TD Cowen 05 Feb 2026 100.00 (68.01%) Beli 77.64
Truist Securities 05 Feb 2026 95.00 (59.61%) Beli 77.64
UBS 05 Feb 2026 120.00 (101.61%) Beli 77.64
Wells Fargo 05 Feb 2026 94.00 (57.93%) Beli 77.64
Barclays 03 Feb 2026 124.00 (108.33%) Beli 91.62
Papar semua

Tiada data dalam julat masa ini.

  • 3M
Tarikh Jenis Butiran
04 Feb 2026 Pengumuman Boston Scientific announces results for fourth quarter and full year 2025

Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2026 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda